APOTEX-MYCOPHENOLATE mycophenolate mofetil 250 mg capsule blister pack

Active ingredient:

mycophenolate mofetil, Quantity: 250 mg

Available from:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

Mycophenolate mofetil

Pharmaceutical form:

Capsule

Composition:

Excipient Ingredients: croscarmellose sodium; indigo carmine; Gelatin; titanium dioxide; purified water; iron oxide red; magnesium stearate; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; Shellac; strong ammonia solution; iron oxide black; potassium hydroxide

Administration route:

Oral

Units in package:

100 capsules, 300 capsules

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Mycophenolate mofetil is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants.,Mycophenolate mofetil is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.

Product summary:

Visual Identification: Opaque blue cap and opaque pink body in Size 1 capsule containing white to off white powder. "M250" and "APO" are imprinted on capsules in black ink.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2011-11-08